BUDESONIDE/ GLYCOPYRRONIUM/ FORMOTEROL 5/7.2/160 (Trixeo Aerosphere® MDI)

Clinical Indication

COPD

Comments

1^st Choice Aerosol

New patients should be initiated on Trixeo (low carbon option)

COPD: In line with LLR COPD guidelines

Asthma: Not licensed

In use shelf-life: 3 months

Date of classification

June 2026

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.